₹ 0.7 Cr
Volume transacted
2.8 K
stocks traded
Last Updated time: 05 Nov 10:18 AM
Remus Pharmaceuticals Ltd
NSE: RemusPharma.
YEARLOW
₹ 1200
Last updated on: Nov 04, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
04 Nov 2024 | 2542.6 | 2625 | 2626 | 2520 |
01 Nov 2024 | 2632.3 | 2648 | 2649 | 2626 |
31 Oct 2024 | 2616.7 | 2620 | 2649 | 2580 |
30 Oct 2024 | 2598.75 | 2580 | 2626.05 | 2560 |
29 Oct 2024 | 2571.45 | 2450 | 2610 | 2450 |
28 Oct 2024 | 2441 | 2406.5 | 2459 | 2380 |
25 Oct 2024 | 2404.75 | 2544 | 2544 | 2399 |
24 Oct 2024 | 2449 | 2462 | 2492 | 2411.5 |
23 Oct 2024 | 2481.8 | 2550 | 2550 | 2402 |
22 Oct 2024 | 2549.7 | 2600 | 2600 | 2526 |
Date | Price |
---|---|
04 Nov 2024 | 2542.6 |
01 Nov 2024 | 2632.3 |
31 Oct 2024 | 2616.7 |
30 Oct 2024 | 2598.75 |
29 Oct 2024 | 2571.45 |
28 Oct 2024 | 2441 |
25 Oct 2024 | 2404.75 |
24 Oct 2024 | 2449 |
23 Oct 2024 | 2481.8 |
22 Oct 2024 | 2549.7 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Remus Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Remus Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Remus Pharmaceuticals to convene AGM
Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...
31 Aug 202415:40
Remus Pharmaceuticals to table results
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...
10 May 202412:07
Remus Pharmaceuticals schedules EGM
Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...
24 Apr 202410:34
Remus Pharmaceuticals revises board meeting date
Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...
20 Apr 202415:16
Remus Pharmaceuticals to consider Dividend
Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 A...
17 Apr 202409:39
Board of Remus Pharmaceuticals recommends interim dividend
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...
20 Oct 202316:09
FAQs for 52 Week Low of Remus Pharmaceuticals Ltd
Why is it important to track the 52-week low of Remus Pharmaceuticals Ltd stocks?
What factors can lead to Remus Pharmaceuticals Ltd stocks hitting a 52-week low?
Should investors buy Remus Pharmaceuticals Ltd stocks when they hit a 52-week low?
How often should investors monitor the 52-week low of Remus Pharmaceuticals Ltd stocks?
How can an investor assess the risk of buying Remus Pharmaceuticals Ltd stock at their 52-week low?
Should investors consider the overall market trend when evaluating Remus Pharmaceuticals Ltd stocks at their 52-week low?
Unlimited trading at just
Rs. 199*